Skip to content

Xiangyang Xu

3 papers in the library · 35 citations · publishing 2022-2025

Papers

Sort Most recent Most cited

S-ketamine alleviates morphine-induced hyperalgesia via decreasing the gut Enterobacteriaceae levels: Comparison with R-ketamine.

Neuroscience March 5, 2025 Hanyu Liu, Siqi Yang, Qi Zhang et al.

Opioid-induced hyperalgesia (OIH) is a serious complication during the pain treatment. Ketamine has been commonly reported to treat OIH, but the mechanisms remain unclear. Gut microbiota is recently recognized as one of the important mechanisms underlying the occurrence and treatment of OIH. However, whether ketamine enantiomers could alleviate OIH through gut microbiota that still needs to be...

The role of CD38 in inflammation-induced depression-like behavior and the antidepressant effect of (R)-ketamine.

Brain, behavior, and immunity October 1, 2023 Xinying Zhang, Teng He, Zifeng Wu et al.

CD38 is involved in immune responses, cell proliferation, and has been identified in the brain, where it is implicated in inflammation processes and psychiatric disorders. We hypothesized that dysfunctional CD38 activity in the brain may contribute to the pathogenesis of depression. To investigate the underlying mechanisms, we used a lipopolysaccharide (LPS)-induced depression model and...

Depression and antidepressant effects of ketamine and its metabolites: The pivotal role of gut microbiota.

Neuropharmacology September 1, 2022 Hao-Ming Hua, Chao Huang, Hanyu Liu et al. 35 citations

The discovery of the robust antidepressant actions of ketamine is regarded as one of the greatest advancements in depression treatment in the past 60 years. Recent findings have provided strong evidence for the presence of bidirectional communication networks between the gastrointestinal tract and the brain in depression. Moreover, increasing evidence supports the antidepressant role of...